Reaktion #73498

ord-2d0e8aff785943749324b2dccdf7ac01

Reaktionsgleichung

COC(=O)C(C(C)=O)C(C)(C)c1ccccc1
methyl 2-acetyl-3-methyl-3-phenylbutanoate
CCN(c1ccccc1)S(=O)(=O)c1ccc(NN)nc1
N-ethyl-6-hydrazino-N-phenylpyridine-3-sulfonamide
CCN(c1ccccc1)S(=O)(=O)c1ccc(-n2[nH]c(C)c(C(C)(C)c3ccccc3)c2=O)nc1
N-ethyl-6-[3-methyl-4-(1-methyl-1-phenylethyl)-5-oxo-2,5-dihydro-1H-pyrazol-1-yl]-N-phenylpyridine-3-sulfonamide
Ausbeute 44.0%

Lösungsmittel

Reaktionsbedingungen

Temperatur
90°CELSIUS
Detaillierte Bedingungen
See reaction.notes.procedure_details.

Aufarbeitung

  1. 1
    EinengenAfter concentrating under reduced pressure
  2. 2
    Waschenwashed with 2×30 mL of saturated NaHCO3 solution
  3. 3
    Trocknendried over Na2SO4
  4. 4
    Filtrationfiltered
  5. 5
    Einengenconcentrated under reduced pressure
  6. 6
    Sonstigepurified by chromatography on a column of silica gel
  7. 7
    Wascheneluting with a cyclohexane/EtOAc gradient of 0 to 20% EtOAc
  8. 8
    EinengenAfter concentrating under reduced pressure, 312 mg of a yellow oil
  9. 9
    Sonstigeare obtained
  10. 10
    SonstigeThe solid obtained
  11. 11
    Filtrationis filtered off
  12. 12
    Sonstigedried under vacuum

Vorschrift

To a solution of 200 mg (0.85 mmol) of methyl 2-acetyl-3-methyl-3-phenylbutanoate in 2 mL of EtOH/AcOH mixture (1:1) are added 249 mg (0.85 mmol) of N-ethyl-6-hydrazino-N-phenylpyridine-3-sulfonamide and the reaction mixture is then heated for 2 hours at 90° C. After concentrating under reduced pressure, the residue is taken up in 100 mL of DCM, washed with 2×30 mL of saturated NaHCO3 solution, dried over Na2SO4, filtered, concentrated under reduced pressure and then purified by chromatography on a column of silica gel, eluting with a cyclohexane/EtOAc gradient of 0 to 20% EtOAc. After concentrating under reduced pressure, 312 mg of a yellow oil are obtained, and are solidified in 20 mL of pentane. The solid obtained is filtered off, and then dried under vacuum. 178 mg of N-ethyl-6-[3-methyl-4-(1-methyl-1-phenylethyl)-5-oxo-2,5-dihydro-1H-pyrazol-1-yl]-N-phenylpyridine-3-sulfonamide are obtained in the form of a white powder.

Quelle

DOI: 10.6084/m9.figshare.5104873.v1Patent: US08541455B2uspto-grants-2013_09